Anonymous
Guest
Anonymous
Guest
Merck Cuts 600 Sales Reps as Part of its Ongoing Reorganization
http://blogs.wsj.com/pharmalot/2014...t-of-its-ongoing-reorganization/?mod=yahoo_hs
As part of its ongoing bid to reorganize and cut costs, Merck is eliminating 600 jobs by the end of next month, according to a recent filing made with the state’s Department of Labor & Industry. A Merck spokeswoman says most of the layoffs involve sales reps that are based around the country and is a part of a broader cost-cutting initiative that was announced last fall.
Indeed, the move comes nine months after the drug maker announced a sweeping retrenchment that involves slashing 8,500 jobs, closing some facilities and ending certain research projects. The stated goal is to save $2.5 billion by the end of next year. The total number of layoffs will amount to 20% of the global workforce of about 81,000 employees at the time the plans were disclosed last October.
Merck has, actually, been cutting costs in a variety of way for years, even before the drug maker paid $41 billion for Schering-Plough MRK -0.19% four years ago. In 2011, for instance, Merck began chopping up to 13,000 jobs in order to save up to $1.5 billion by 2015.
http://blogs.wsj.com/pharmalot/2014...t-of-its-ongoing-reorganization/?mod=yahoo_hs
As part of its ongoing bid to reorganize and cut costs, Merck is eliminating 600 jobs by the end of next month, according to a recent filing made with the state’s Department of Labor & Industry. A Merck spokeswoman says most of the layoffs involve sales reps that are based around the country and is a part of a broader cost-cutting initiative that was announced last fall.
Indeed, the move comes nine months after the drug maker announced a sweeping retrenchment that involves slashing 8,500 jobs, closing some facilities and ending certain research projects. The stated goal is to save $2.5 billion by the end of next year. The total number of layoffs will amount to 20% of the global workforce of about 81,000 employees at the time the plans were disclosed last October.
Merck has, actually, been cutting costs in a variety of way for years, even before the drug maker paid $41 billion for Schering-Plough MRK -0.19% four years ago. In 2011, for instance, Merck began chopping up to 13,000 jobs in order to save up to $1.5 billion by 2015.